EUVIMEDSkopri EUVIMED
Crossref

Treatment of giant neurofibromas in extremities and trunk wall of neurofibromatosis type 1 patients: a Chinese 12‐year single‐institution experience

Qianqian Gao, Zhe Yang, Ning Ma, Sen Chen, Yangqun Li iD

ANZ Journal of Surgery · 2024

DOI: 10.1111/ans.19101 ↗

At a glance

Journal article in ANZ Journal of Surgery, 2024. Written by Qianqian Gao and 4 co-authors. Institution: The 2nd Department of Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Major MEDLINE topics: Neurofibromatosis 1. Cited 1 times so far (Crossref); 32 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Backgrounds Giant neurofibromas occurring in individuals diagnosed with neurofibromatosis type 1 (NF1) often result in considerable disfigurement, functional impairment, and diminished quality of life. Although debulking surgery poses inherent risks of complications, it remains the most efficacious approach to address these issues. The primary objective of this study was to share our surgical experience with giant neurofibromas in the extremities and trunk wall of NF1 patients which may help surgeons to minimize intraoperative bleeding and facilitate tumor excision.

Methods

A retrospective review was conducted at a single center, encompassing 36 NF1 patients with giant neurofibromas in the extremities and trunk wall who underwent debulking surgery from July 2010 to July 2022.

Results

Twenty‐one male and fifteen female NF1 patients who received one to four surgical interventions were evaluated. The average age at the time of surgery was 17.8 years. The median follow‐up time was 52 months. Our findings revealed relatively low rates of complications and recurrence. Notably, patients expressed satisfaction with both the aesthetic and functional results.

Conclusions

Debulking surgery of giant neurofibromas in the extremities and trunk wall of NF1 patients can effectively reduce the tumor burden, leading to improvements in both the appearance and function.

Subjects

MeSH terms (MEDLINE)

Neurofibromatosis 1HumansMaleFemaleRetrospective StudiesAdolescentAdultYoung AdultChinaExtremitiesChildTorsoNeurofibromaTreatment OutcomeCytoreduction Surgical ProceduresMiddle AgedQuality of LifeFollow-Up StudiesEast Asian People

Author keywords

Chinesegiant neurofibromasneurofibromatosis type 1surgical treatmentthe extremities and trunk wall

Authors and institutions

  • The 2nd Department of Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID profiles: Yangqun Li

Cite

APA

Gao, Q., Yang, Z., Ma, N., Chen, S., & Li, Y. (2024). Treatment of giant neurofibromas in extremities and trunk wall of neurofibromatosis type 1 patients: a Chinese 12‐year single‐institution experience. ANZ Journal of Surgery. https://doi.org/10.1111/ans.19101

Vancouver

Gao Q, Yang Z, Ma N, Chen S, Li Y. Treatment of giant neurofibromas in extremities and trunk wall of neurofibromatosis type 1 patients: a Chinese 12‐year single‐institution experience. ANZ Journal of Surgery. 2024. doi:10.1111/ans.19101

BibTeX
@article{Gao2024,
  author = {Gao, Qianqian and Yang, Zhe and Ma, Ning and Chen, Sen and Li, Yangqun},
  title = {Treatment of giant neurofibromas in extremities and trunk wall of neurofibromatosis type 1 patients: a Chinese 12‐year single‐institution experience},
  journal = {ANZ Journal of Surgery},
  year = {2024},
  doi = {10.1111/ans.19101}
}
Start for free →